ICNMD 2020: Presenting results from PRISM, a study in patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
September 11, 2020
LFB XENOTHERA agreement to manufacture XAV-19 candidate therapy for coronavirus, including COVID-19, infections
April 15, 2020
FDA approves SEVENFACT®, a new recombinant coagulation Factor VIIa [coagulation factor VIIa
(recombinant)-jncw]
April 6, 2020
Development of potential COVID-19 hyperimmune therapy
April 6, 2020
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Undefined cookies are those that are being analyzed and have not been classified into a category as yet.
